期刊文献+

贫血对慢性心力衰竭患者住院期间死亡的影响 被引量:5

Anemia:a dependent risk factor for death during hospitalization in patients with chronic heart failure
原文传递
导出
摘要 目的:了解慢性心力衰竭(CHF)患者贫血的发生率及其对住院期间死亡的影响。方法:收集2003-01-2008-06在我院住院的CHF患者的临床资料进行回顾性分析,根据患者血红蛋白(Hb)水平分为Hb正常组、轻度贫血组以及中重度贫血组3组。结果:贫血在CHF患者的发生率为32.5%;住院期间死亡患者的Hb、RBC均明显低于好转的患者(P〈0.01),贫血患者在住院期间的死亡率明显高于无贫血的患者(P〈0.01),以二分类Logistic回归住院期间死亡的危险因素进行分析得出:贫血的偏回归系数为1.296(P=0.039),优势比(OR)为3.655(95%CI:1.069-12.499);对于心功能NYHAⅢ-Ⅳ级的CHF患者,Hb的偏回归系数为-0.073(P=0.041),OR为0.93(95%CI:0.864-0.995)。结论:CHF患者贫血的发生率较高,贫血是CHF患者住院期间死亡的独立危险因素,Hb降低增加心功能Ⅲ-Ⅳ级的CHF患者住院期间的死亡。 Objective:To investigate the morbidity of anemia in patients with chronic heart failure (CHF) and its prognostic role in predicting death during hospitalization.Methods:The clinical data of patients with CHF were collected, and analyzed according to the hemoglobin (Hb) levels in serum.Results:The morbidity of anemia was 32.5% in patients with CHF, and the rate of death in CHF patients with anemia was higher than those without anemia (P〈0.01). Meanwhile, the levels of Hb and red blood cell count (RBC) were significantly decreased in died patients compared to those in survived patients during hospitalization (P〈0.01). The results of analysis by binary logistic regression showed that the coefficient of partial regression was 1.296 (P=0.039) and the odds ratio (OR) was 3.655 (95% CI:1.069-12.499) for anemia. But for Hb in patients with CHF of NYHA Ⅲ-Ⅳ, the partial regression coefficient was -0.073 (P=0.041) and the OR was 0.93 (95% CI: 0.864-0.995), respectively.Conclusion:The morbidity of anemia was high in patients with CHF, and anemia was a independent risk factor for death during hospitalization in patients with CHF.
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2010年第4期247-250,共4页 Journal of Clinical Cardiology
关键词 慢性心力衰竭 贫血 危险因素 预后 chronic heart failure anemia risk factor prognosis
  • 相关文献

参考文献8

  • 1REDFIELD M M,JACOBSEN S J,BURNETT J C,et al.Burden of systolic and diastolic ventricular dysfunction in the community:appreciating the scope of the heart failure epidemic[J].JAMA,2003,289:194-202.
  • 2LLOYD-JONES D M,LARSON M G,LEIP E P,et al.Lifetime risk for developing congestive heart failure:the Framingham Heart Study[J].Circulation,2002,106:3068-3072.
  • 3SHARON A H,WILLIAM T A,MARSHALL H C,et al.ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult:A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure):Developed in Collaboration With the American College of Chest Physicians and the International Society for Heart and Lung Transplantation:Endorsed by the Heart Rhythm Society[J].Circulation,2005,112:e154-e235.
  • 4叶任高.内科学.12版[M].北京:人民卫生出版社,2001:586-.
  • 5FELKER G M,KIRKWOOD F,ADAMS K F,et al.Anemia as a risk factor and therapeutic target in heart failure[J].J Am Coll Cardiol,2004,44:959-966.
  • 6TANG Y D,KATZ S D.Anemia in chronic heart failure.Prevalence,etiology,clinical correlates and treatment options[J].Circulation,2006,113:2454-2461.
  • 7ANAND I S,KUSKOWSKI M A,RECTOR T S,et al.Anemia and change in hemoglobin over time related to mortality and morbidity in patients with chronic heart failure:results from Val-HeFT[J].Circulation,2005,112:1121-1127.
  • 8陈俊华,董先杰,刘勇.慢性心力衰竭患者中红细胞分布宽度与心功能的关系[J].临床心血管病杂志,2009,25(2):155-156. 被引量:33

二级参考文献6

  • 1FELKER G M, ALLEN L A, POCOCK S J, et al. Red cell distribution width as a novel prognostic marker in heart failure: Data from the CHARM program and the duke databank[J]. J Am Coll Cardiol, 2007,50:40-47.
  • 2DUFFY T P. Approach to the patient with anemia [M]//KELLEY W N, DUPONT H L, GLICK J H, eds. Kelley's textbook of internal medicine. 3rd ed. Philadelphia: Lippincott Williams and Wilkins', 1997:1295-1299.
  • 3OZKALEMKAS F, ALI R, OZKOCAMAN V, et al. The bone marrow aspirate and biopsy in the diagnosis of unsuspected nonhematologic malignancy: a clinical study of 19 cases[J]. BMC Cancer, 2005, 5: 144- 149.
  • 4FELKER G M, ADAMS K F Jr, GATTIS W A, et al. Anemia as a risk factor and therapeutic target in heart failure[J]. J Am Coll Cardiol, 2004,44:959 - 966.
  • 5DESWAL A, PETERSON M J, FELDMAN A M, et al. Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone Trial (VEST) [ J ]. Circulation, 2001, 103:2055-2059.
  • 6GRADMAN A, DEEDWANIA P, CODY R, et al. Predictors of total mortality and sudden death in mild to moderate heart failure [J]. J Am Coll Cardiol, 1989,14:564-570.

共引文献32

同被引文献52

  • 1高薇,蔡久英,江珊.心力衰竭患者部分神经激素和细胞因子的变化及卡维地洛的干预作用[J].临床心血管病杂志,2006,22(8):458-461. 被引量:8
  • 2郭玲,王爱红,吕琳,鹿克风,孙永乐.EPO辅助治疗慢性心力衰竭合并贫血52例临床观察[J].山东医药,2007,47(5):57-58. 被引量:10
  • 3陆再英,钟南山.内科学[M].第7版.北京:人民卫生出版社,2010:387-395.
  • 4Caiola K, Cheng JW. Use of erythropoietin in heart failure management [ J ]. The Annals of Pharmacotherapy, 2004,38 (12) :2145 - 2149.
  • 5Anand I, McMurray JJV, Whitmore J, et al. Anemia and its relationship to clinical outcome in heart failure [J ]. Cir- culation,2004,110(2) : 149 - 154.
  • 6Mitchell JE. Emergine role of anemia in heart failure [ J ]. Am J Cardiol,2007,99(6B) :15D.
  • 7Silverberg DS, Wexler D, Laina A. The importance of ane- mia and its correction in the management of severe congestive heart failure [J]. Eur J Hear Fail,2002,4:681 - 686.
  • 8Kirkwood F, Adams. Prospective ass essment of the occur- rence of anemia in patients with heart failure: Results from the study of anemia in a heart failure population [ J ]. Am Heart J,2009,157(9) :926.
  • 9Opaich C, Cazzola M, Scelsi L, et al. Blunted erythropoi- etin production and defective iron supply for erythropoiesis ah major causes of anemia in patiens with chronic heart failure [J]. Eur Heart J ,2005,26(21) :2232.
  • 10Horl WH. Iron therapy for renal anemia:how much need- ed ,how much harmful? [ J ]. Pediatr Nephrol, 2007,224 : 480 - 489.

引证文献5

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部